| Product Code: ETC6847857 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Croatia Clinical Oncology NGS Market Overview |
3.1 Croatia Country Macro Economic Indicators |
3.2 Croatia Clinical Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Croatia Clinical Oncology NGS Market - Industry Life Cycle |
3.4 Croatia Clinical Oncology NGS Market - Porter's Five Forces |
3.5 Croatia Clinical Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Croatia Clinical Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.7 Croatia Clinical Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Croatia Clinical Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Croatia Clinical Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Croatia leading to higher demand for clinical oncology services |
4.2.2 Technological advancements in Next-Generation Sequencing (NGS) driving the adoption of precision medicine in oncology |
4.2.3 Growing awareness about the benefits of NGS testing for personalized treatment plans |
4.3 Market Restraints |
4.3.1 High costs associated with NGS testing and equipment may limit accessibility for some patients |
4.3.2 Regulatory challenges and compliance requirements in Croatia's healthcare system |
4.3.3 Limited expertise and resources for implementing and interpreting NGS results in clinical practice |
5 Croatia Clinical Oncology NGS Market Trends |
6 Croatia Clinical Oncology NGS Market, By Types |
6.1 Croatia Clinical Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Croatia Clinical Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Croatia Clinical Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Croatia Clinical Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Croatia Clinical Oncology NGS Market Revenues & Volume, By Targeted Sequencing & Resequencing Centrifuges, 2021- 2031F |
6.2 Croatia Clinical Oncology NGS Market, By Workflow |
6.2.1 Overview and Analysis |
6.2.2 Croatia Clinical Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.2.3 Croatia Clinical Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.2.4 Croatia Clinical Oncology NGS Market Revenues & Volume, By Data Analysis, 2021- 2031F |
6.3 Croatia Clinical Oncology NGS Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Croatia Clinical Oncology NGS Market Revenues & Volume, By Screening, 2021- 2031F |
6.3.3 Croatia Clinical Oncology NGS Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F |
6.3.4 Croatia Clinical Oncology NGS Market Revenues & Volume, By Other Diagnostics, 2021- 2031F |
6.4 Croatia Clinical Oncology NGS Market, By End-use |
6.4.1 Overview and Analysis |
6.4.2 Croatia Clinical Oncology NGS Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Croatia Clinical Oncology NGS Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Croatia Clinical Oncology NGS Market Revenues & Volume, By Laboratories, 2021- 2031F |
7 Croatia Clinical Oncology NGS Market Import-Export Trade Statistics |
7.1 Croatia Clinical Oncology NGS Market Export to Major Countries |
7.2 Croatia Clinical Oncology NGS Market Imports from Major Countries |
8 Croatia Clinical Oncology NGS Market Key Performance Indicators |
8.1 Average turnaround time for NGS test results |
8.2 Adoption rate of NGS testing in clinical oncology practices |
8.3 Number of collaborations between healthcare institutions and NGS technology providers |
8.4 Rate of reimbursement for NGS testing by healthcare payers |
8.5 Patient satisfaction scores related to NGS testing experience |
9 Croatia Clinical Oncology NGS Market - Opportunity Assessment |
9.1 Croatia Clinical Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Croatia Clinical Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.3 Croatia Clinical Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Croatia Clinical Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Croatia Clinical Oncology NGS Market - Competitive Landscape |
10.1 Croatia Clinical Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Croatia Clinical Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here